HilleVax, Inc.

HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines. Our initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection.

Website: hillevax.com

Employees: 20 - 49

HQ: 617-213-5054

Location: Boston, MA, US

Revenue: 2.5 - 5 Million

N/A

HilleVax, Inc. Technologies

Email Providers

Outlook

Load Balancers

Varnish

CMS

WordPress.org

Other

Microsoft Office 365

Recruitment

Jobvite

View All Technologies Used At HilleVax, Inc.

Similar companies to HilleVax, Inc.

Vera Therapeutics, Inc. Mythic Therapeutics, Inc. Q32 Bio Inc Intergalactic Therapeutics Inc. CereVasc, Inc. AnTolRx Inc PurpleLab Rgenta Therapeutics Instylla Inc. ImmuneID, Inc. Aktis Oncology Bota Bio Carmot Therapeutics Mednition Inc Signal Partners Cleveland Diagnostics, Inc. Rectify Pharmaceuticals, Inc. Auron Therapeutics Avilar Therapeutics, Inc. AltruBio

Contacting HilleVax, Inc.: Connect with Executives and Employees

Get in Touch with HilleVax, Inc. Executives and Employees

Connecting with HilleVax, Inc.'s Executives and Workforce

Accessing Contact Information for HilleVax, Inc. Executives

Connecting with HilleVax, Inc.: Reach Out to Their Team

Discover How to Contact HilleVax, Inc. Executives and Staff

Looking to connect with HilleVax, Inc. executives or employees?

Seeking to Get in Touch with HilleVax, Inc. Executives or Staff?

Want to Reach Out to HilleVax, Inc. Executives or Team Members?

In Search of Contact Details for HilleVax, Inc. Professionals?

Connecting with HilleVax, Inc.: Contacting Executives and Staff

Browse companies

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

HilleVax, Inc.

HilleVax, Inc. Employees

Patrick Heron

Tawnya Nead

Kristin Yannetti

Paul Troccolo

Paul Bavier

Mark Lyons

Ryan Thurston

HilleVax, Inc. Senior Management

Robert Hershberg

HilleVax, Inc. Details